Scientific and technological advances are making it easier than ever for life sciences companies to expand clinical trial candidate bases, so, in many cases, they should be able to more accurately reflect their real-world patient population. Learn 5 key considerations for assessing and restructuring clinical trial design and processes to achieve better representation of target populations.
By Vijaya Prajwala, Liisa M. Eisenlohr, and Enno Behrendt.
This byline originally appeared in Applied Clinical Trials Online.
Guidehouse is a global advisory, technology, and managed services firm delivering value to commercial businesses and federal, state, and local governments. Serving industries focused on communities, energy, infrastructure, healthcare, financial services, defense, and national security, Guidehouse positions clients for AI-led innovation, efficiency, and resilience.